Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

MLA

Slattery, Martha L., et al. “Genetic Variation in a Metabolic Signaling Pathway and Colon and Rectal Cancer Risk: MTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.” Carcinogenesis, vol. 31, no. 9, Sept. 2010, pp. 1604–11. EBSCOhost, https://doi.org/10.1093/carcin/bgq142.

APA

Slattery, M. L., Herrick, J. S., Lundgreen, A., Fitzpatrick, F. A., Curtin, K., & Wolff, R. K. (2010). Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis, 31(9), 1604–1611. https://doi.org/10.1093/carcin/bgq142

Chicago

Slattery, Martha L, Jennifer S Herrick, Abbie Lundgreen, Francis A Fitzpatrick, Karen Curtin, and Roger K Wolff. 2010. “Genetic Variation in a Metabolic Signaling Pathway and Colon and Rectal Cancer Risk: MTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.” Carcinogenesis 31 (9): 1604–11. doi:10.1093/carcin/bgq142.